Heart Failure Reviews

Papers
(The median citation count of Heart Failure Reviews is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome74
Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program65
Trends and complications associated with acute new-onset heart failure: a National Readmissions Database–based cohort study43
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis42
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction41
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making39
Polypharmacy definition and prevalence in heart failure: a systematic review38
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 202037
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis36
Right ventricular failure: a comorbidity or a clinical emergency?35
The cardiosplenic axis: the prognostic role of the spleen in heart failure31
Can mechanical circulatory support be an effective treatment for HFpEF patients?30
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris28
Correction to: Is it time to revisit ICD indications?28
The role of TAVR in patients with heart failure: do we have the responses to all questions?28
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction28
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?26
Mechanisms, time course and predictability of premature ventricular contractions cardiomyopathy—an update on its development and resolution25
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review25
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition25
Dependence and reduced motor function in heart failure: future directions for well-being25
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?24
Advanced cardiovascular multimodal imaging and aortic stenosis24
Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers23
Peripartum cardiomyopathy: a review19
Filamin C in cardiomyopathy: from physiological roles to DNA variants19
Clinical management of amyloid cardiomyopathy19
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers18
Resistance training in heart failure patients: a systematic review and meta-analysis18
Speckle tracking echocardiography in heart failure development and progression in patients with apneas18
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases17
The use of diflunisal for transthyretin cardiac amyloidosis: a review17
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging17
Advanced airway management and respiratory care in decompensated pulmonary hypertension16
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease15
ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study14
Targeting mitochondrial dysfunction with elamipretide14
State-of-the-art review on management of end-stage heart failure in amyloidosis: transplant and beyond14
Letter to the editor to update the article “Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials”14
Letter to the Editor13
Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure13
Left ventricular assist device in cardiac amyloidosis: friend or foe?13
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 202112
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era12
Experimental heart failure models in small animals12
Predictors of fatal arrhythmic events in patients with non-compaction cardiomyopathy: a systematic review12
Echocardiographic assessment of cardiac amyloidosis11
Correction to: Cardiac xenotransplantation: a promising way to treat advanced heart failure11
New onset nonischemic cardiomyopathy post liver transplantation11
Deciphering hypertrophic cardiomyopathy with electrocardiography10
Diagnosis of cardiac sarcoidosis: a primer for non-imagers10
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy10
Large animal models of heart failure with preserved ejection fraction10
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure9
Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials9
New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy9
Functional tricuspid regurgitation, related right heart remodeling, and available treatment options: good news for patients with heart failure?9
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature9
Cardiovascular positron emission tomography: established and emerging role in cardiovascular diseases8
Stepwise approach for diagnosis and management of Takotsubo syndrome with cardiac imaging tools8
Correction to: Polypharmacy definition and prevalence in heart failure: a systematic review8
Soluble ST2: a valuable prognostic marker in heart failure8
0.42780804634094